SCHEMBL16587285

SCHEMBL16587285

COCC(=O)c1nn(-c2ccccc2Cl)c(-c2noc(-c3cccc(C)c3)n2)c1Cl

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HAVCR2 Q8TDQ0 5/20 0.42
NPC1 O15118 6/20 0.40
RAB9A P51151 4/20 0.40
HSD17B10 Q99714 3/20 0.40
TSHR P16473 3/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
KDM4E B2RXH2 2/20 0.40
TP53 P04637 4/20 0.39
GRM5 P41594 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.38
ALDH1A1 P00352 3/20 0.38
HPGD P15428 2/20 0.38
LMNA P02545 2/20 0.38
NFKB1 P19838 2/20 0.38
NFKB2 Q00653 2/20 0.38
RELA Q04206 2/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
MAPT P10636 2/20 0.38
USP2 O75604 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16587287 0.92 NPC1 (0.42) HAVCR2NPC1RAB9AHSD17B10TSHR
SCHEMBL16452576 0.89 NPC1 (0.42) HAVCR2NPC1RAB9AHSD17B10TSHR
SCHEMBL16587446 0.88 RXRA (0.46) NPC1RAB9ASMN1; SMN2TP53ALDH1A1
SCHEMBL16452725 0.87 NR1H4 (0.43) HAVCR2NPC1RAB9AHSD17B10TSHR
SCHEMBL16452588 0.87 PDE4B (0.46) HAVCR2NPC1RAB9AHSD17B10TSHR
SCHEMBL16452724 0.82 NPC1 (0.41) HAVCR2NPC1RAB9AHSD17B10TSHR
SCHEMBL16587286 0.82 NPC1 (0.43) HAVCR2NPC1RAB9AHSD17B10TSHR
SCHEMBL16452552 0.81 NPC1 (0.44) HAVCR2NPC1RAB9AHSD17B10TSHR
SCHEMBL16452732 0.81 TP53 (0.43) HAVCR2NPC1RAB9AHSD17B10TSHR
SCHEMBL16452512 0.81 NPC1 (0.43) HAVCR2NPC1RAB9AHSD17B10TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8987318-B2 Liver X receptor (LXR) modulators for the treatment of dermal diseases, disorders and conditions ALEXAR THERAPEUTICS, INC. (US) 2015-03-24 US disclosed